We are live on ! Find out more
PCM

Price Capital Management Portfolio holdings

AUM $7.05M
1-Year Est. Return 47.39%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+47.39%
3 Year Est. Return
+124.26%
5 Year Est. Return
10 Year Est. Return
AUM
$161M
AUM Growth
+$48M
Cap. Flow
+$40.3M
Cap. Flow %
24.95%
Top 10 Hldgs %
23.99%
Holding
322
New
258
Increased
Reduced
45
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 22.56%
2 Consumer Discretionary 15.32%
3 Technology 10.47%
4 Financials 8.71%
5 Industrials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOH icon
126
Bank of Hawaii
BOH
$3.13B
$343K 0.21%
+5,609
New +$331K
CYN
127
DELISTED
CITY NATIONAL CORPORATION
CYN
$343K 0.21%
+3,853
New +$333K
BKU icon
128
Bankunited
BKU
$3.36B
$342K 0.21%
+10,461
New +$321K
FHN icon
129
First Horizon
FHN
$12.1B
$342K 0.21%
+23,921
New +$330K
RGEN icon
130
Repligen
RGEN
$9.25B
$289K 0.18%
+9,526
New +$247K
CBM
131
DELISTED
Cambrex Corporation
CBM
$285K 0.18%
+7,197
New +$213K
CBPO
132
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$277K 0.17%
+2,900
New +$217K
BMRN icon
133
BioMarin Pharmaceuticals
BMRN
$12.4B
$267K 0.17%
+2,145
New +$227K
LUMO
134
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$267K 0.17%
542
-3,001
-85% -$1.16M
REGN icon
135
Regeneron Pharmaceuticals
REGN
$80.8B
$259K 0.16%
+574
New +$243K
MACK
136
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$256K 0.16%
2,738
-12,266
-82% -$1.04M
AMGN icon
137
Amgen
AMGN
$222B
$253K 0.16%
+1,580
New +$249K
NTUS
138
DELISTED
Natus Medical Inc
NTUS
$253K 0.16%
6,400
-26,207
-80% -$966K
INSM icon
139
Insmed
INSM
$28.6B
$252K 0.16%
+12,102
New +$213K
DLX icon
140
Deluxe
DLX
$1.15B
$249K 0.15%
+3,600
New +$234K
INCY icon
141
Incyte
INCY
$24.4B
$249K 0.15%
+2,717
New +$225K
AAL icon
142
American Airlines Group
AAL
$10.6B
$248K 0.15%
+4,700
New +$239K
BIIB icon
143
Biogen
BIIB
$30.7B
$247K 0.15%
+586
New +$231K
JAZZ icon
144
Jazz Pharmaceuticals
JAZZ
$16.7B
$247K 0.15%
+1,428
New +$245K
CRL icon
145
Charles River Laboratories
CRL
$12.8B
$246K 0.15%
+3,097
New +$228K
ANDV
146
DELISTED
Andeavor
ANDV
$246K 0.15%
+2,700
New +$227K
ARIA
147
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$245K 0.15%
+29,749
New +$220K
AXON
148
Axon Enterprise
AXON
$46.4B
$244K 0.15%
10,100
-78,710
-89% -$2M
GD icon
149
General Dynamics
GD
$106B
$244K 0.15%
+1,800
New +$247K
LEN icon
150
Lennar Class A
LEN
$21.2B
$244K 0.15%
+4,938
New +$225K

Similar funds

Price Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Price Capital Management held 322 positions worth $161M, up 42% from $113M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Price Capital Management deployed $40.3M of net new capital in Q1 2015, opening 258 new positions. Its largest new stake was Church & Dwight Co: 168,910 shares worth $722K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Axon Enterprise, an estimated $2M trimmed.

  • Price Capital Management's largest Q1 2015 buy was Church & Dwight Co: 168,910 shares worth $722K.
  • Price Capital Management's biggest Q1 2015 reduction was Axon Enterprise, cutting an estimated $2M.
  • Price Capital Management fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2015, selling an estimated $12.3M.
  • Price Capital Management's ten largest holdings make up 24% of its $161M portfolio in Q1 2015.
  • Price Capital Management opened 258 new positions and closed 19 in Q1 2015.
  • Price Capital Management's portfolio value rose 42% quarter-over-quarter to $161M.

Based on Price Capital Management's 13F filing for Q1 2015, filed 13 May 2015.